Atorvastatin in improvement of cognitive impairments caused by amyloid β in mice: involvement of inflammatory reaction

Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage

(2015) Hai-juan Sui et al.   ACTA PHARMACOLOGICA SINICA

Protonation State and Hydration of Bisphosphonate Bound to Farnesyl Pyrophosphate Synthase

(2015) Takeshi Yokoyama et al.   JOURNAL OF MEDICINAL CHEMISTRY

Effects of Aβ exposure on long-term associative memory and its neuronal mechanisms in a defined neuronal network

(2015) Lenzie Ford et al.   Scientific Reports

Madecassoside prevents Aβ25–35-induced inflammatory responses and autophagy in neuronal cells through the class III PI3K/Beclin-1/Bcl-2 pathway

(2014) Baoshun Du et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Functional Characterization of the Xanthophyllomyces dendrorhous Farnesyl Pyrophosphate Synthase and Geranylgeranyl Pyrophosphate Synthase Encoding Genes That Are Involved in the Synthesis of Isoprenoid Precursors

(2014) Jennifer Alcaíno et al.   PLoS One

Cardioprotection by Farnesol: Role of the Mevalonate Pathway

(2013) Gergő Szűcs et al.   CARDIOVASCULAR DRUGS AND THERAPY

Diammonium Glycyrrhizinate Attenuates Aβ1-42-Induced Neuroinflammation and Regulates MAPK and NF-κB PathwaysIn VitroandIn Vivo

(2012) Hui Zhao et al.   CNS Neuroscience & Therapeutics

Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer’s disease

(2012) Tomoko Kurata et al.   NEUROLOGICAL RESEARCH

Anti-amnesic effect of neurosteroid PREGS in Aβ25–35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection

(2012) Rong Yang et al.   NEUROPHARMACOLOGY

Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation

(2011) R.A. Mans et al.   NEUROSCIENCE

A Meta-Analysis of Cytokines in Alzheimer's Disease

(2010) Walter Swardfager et al.   BIOLOGICAL PSYCHIATRY

Conformations and Biological Activities of Amyloid Beta Peptide 25-35

(2010) L. Millucci et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage

(2010) Tetsadê C.B. Piermartiri et al.   EXPERIMENTAL NEUROLOGY

Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases

(2010) Qing Wang et al.   EXPERIMENTAL NEUROLOGY

Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency

(2010) Annalisa Marcuzzi et al.   INFLAMMATION RESEARCH

Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β,tauand neuroinflammation

(2010) Juliana Bender Hoppe et al.   JOURNAL OF PINEAL RESEARCH

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats

(2010) Yu-Fang Cheng et al.   PSYCHOPHARMACOLOGY

Statins Reduce the Neurofibrillary Tangle Burden in a Mouse Model of Tauopathy

(2009) Moran Boimel et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice

(2009) R.A. Mans et al.   NEUROSCIENCE